Detalhe da pesquisa
1.
Antibiotics With or Without Rifaximin for Acute Hepatic Encephalopathy in Critically Ill Patients With Cirrhosis: A Double-Blind, Randomized Controlled (ARiE) Trial.
Am J Gastroenterol
; 2024 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37942950
2.
Primary Norfloxacin Prophylaxis for APASL-Defined Acute-on-Chronic Liver Failure: A Placebo-Controlled Double-Blind Randomized Trial.
Am J Gastroenterol
; 117(4): 607-616, 2022 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35041634
3.
Plasma metabolite profiling identifies non-diabetic CP patients with metabolic alterations progressing to prediabetes prior to HbA1c.
Clin Transl Gastroenterol
; 2024 Apr 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-38661171
4.
Heterologous Booster Dose with CORBEVAX following Primary Vaccination with COVISHIELD Enhances Protection against SARS-CoV-2.
Vaccines (Basel)
; 10(12)2022 Dec 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-36560556
5.
Poor immune response to coronavirus disease vaccines in decompensated cirrhosis patients and liver transplant recipients.
Vaccine
; 40(48): 6971-6978, 2022 11 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-36374707
6.
Adipocyte Fatty Acid-Binding Protein as a Predictor of Outcome in Alcohol-induced Acute-On-Chronic Liver Failure.
J Clin Exp Hepatol
; 11(2): 201-208, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33746445